111 related articles for article (PubMed ID: 36763086)
1. Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2.
Han D; Li X; Cheng Y
Chem Res Toxicol; 2023 Mar; 36(3):360-368. PubMed ID: 36763086
[TBL] [Abstract][Full Text] [Related]
2. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.
Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ
Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922
[No Abstract] [Full Text] [Related]
3. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
4. CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis.
Dai X; Chen X; Chen W; Ou Y; Chen Y; Wu S; Zhou Q; Yang C; Zhang L; Jiang H
Epigenetics; 2023 Dec; 18(1):2178802. PubMed ID: 36840946
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression.
Chen JL; Li J; Kiriluk KJ; Rosen AM; Paner GP; Antic T; Lussier YA; Vander Griend DJ
Clin Cancer Res; 2012 Aug; 18(16):4291-302. PubMed ID: 22723371
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of MEIS2 in prostate cancer recurrence.
Nørgaard M; Haldrup C; Bjerre MT; Høyer S; Ulhøi B; Borre M; Sørensen KD
Clin Epigenetics; 2019 Oct; 11(1):147. PubMed ID: 31640805
[TBL] [Abstract][Full Text] [Related]
8. Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway.
Wen X; Liu M; Du J; Wang X
Bioengineered; 2021 Dec; 12(1):1766-1772. PubMed ID: 33975520
[TBL] [Abstract][Full Text] [Related]
9. Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation.
Alshalalfa M; Abou-Ouf H; Davicioni E; Karnes RJ; Alhajj R; Bismar TA
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2223-2231. PubMed ID: 33864110
[TBL] [Abstract][Full Text] [Related]
10. miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.
Sun X; Li Y; Yu J; Pei H; Luo P; Zhang J
Jpn J Clin Oncol; 2015 May; 45(5):474-82. PubMed ID: 25921099
[TBL] [Abstract][Full Text] [Related]
11. ERN1 dependent impact of glucose and glutamine deprivations on PBX3, PBXIP1, PAX6, MEIS1, and MEIS2 genes expression in U87 glioma cells.
Krasnytska DO; Viletska YM; Minchenko DO; Khita OO; Tsymbal DO; Cherednychenko AA; Kozynkevych HE; Oksiom NS; Minchenko OH
Endocr Regul; 2023 Jan; 57(1):37-47. PubMed ID: 36753664
[No Abstract] [Full Text] [Related]
12. MEIS2 suppresses breast cancer development by downregulating IL10.
Xiao Y; Liu Y; Sun Y; Huang C; Zhong S
Cancer Rep (Hoboken); 2024 May; 7(5):e2064. PubMed ID: 38711262
[TBL] [Abstract][Full Text] [Related]
13. The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors.
Abruzzese MP; Bilotta MT; Fionda C; Zingoni A; Soriani A; Petrucci MT; Ricciardi MR; Molfetta R; Paolini R; Santoni A; Cippitelli M
Cell Death Dis; 2019 Apr; 10(4):324. PubMed ID: 30975979
[TBL] [Abstract][Full Text] [Related]
14. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
15. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.
VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ
Elife; 2020 Jun; 9():. PubMed ID: 32553107
[TBL] [Abstract][Full Text] [Related]
16. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
Jeong JH; Park SJ; Dickinson SI; Luo JL
Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
[TBL] [Abstract][Full Text] [Related]
17. MEIS2 promotes cell migration and invasion in colorectal cancer.
Wan Z; Chai R; Yuan H; Chen B; Dong Q; Zheng B; Mou X; Pan W; Tu Y; Yang Q; Tu S; Hu X
Oncol Rep; 2019 Jul; 42(1):213-223. PubMed ID: 31115559
[TBL] [Abstract][Full Text] [Related]
18. MEIS and PBX homeobox proteins in ovarian cancer.
Crijns AP; de Graeff P; Geerts D; Ten Hoor KA; Hollema H; van der Sluis T; Hofstra RM; de Bock GH; de Jong S; van der Zee AG; de Vries EG
Eur J Cancer; 2007 Nov; 43(17):2495-505. PubMed ID: 17949970
[TBL] [Abstract][Full Text] [Related]
19. Meis2 is a Pax6 co-factor in neurogenesis and dopaminergic periglomerular fate specification in the adult olfactory bulb.
Agoston Z; Heine P; Brill MS; Grebbin BM; Hau AC; Kallenborn-Gerhardt W; Schramm J; Götz M; Schulte D
Development; 2014 Jan; 141(1):28-38. PubMed ID: 24284204
[TBL] [Abstract][Full Text] [Related]
20. Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.
Bjerke GA; Hyman-Walsh C; Wotton D
Mol Cell Biol; 2011 Sep; 31(18):3723-33. PubMed ID: 21746878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
